This company listing is no longer active
Epizyme Gestione
Gestione criteri di controllo 2/4
Informazioni chiave
Grant Bogle
Amministratore delegato
US$3.0m
Compenso totale
Percentuale dello stipendio del CEO | 9.9% |
Mandato del CEO | less than a year |
Proprietà del CEO | n/a |
Durata media del management | 2.3yrs |
Durata media del Consiglio di amministrazione | 10.2yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Epizyme GAAP EPS of -$0.21, revenue of $27.5M
Aug 09Epizyme Acquisition By Ipsen: CVR Value
Jul 05Some Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Made A Major Cut To Next Year's Estimates
May 16Epizyme: Taking Advantage Of Recent Sell-Off
Nov 25Health Check: How Prudently Does Epizyme (NASDAQ:EPZM) Use Debt?
Sep 14Industry Analysts Just Made A Sizeable Upgrade To Their Epizyme, Inc. (NASDAQ:EPZM) Revenue Forecasts
Aug 10Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge
Jun 22Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?
Jun 08Epizyme gains as peer Constellation attracts sizable premium from MorphoSys
Jun 02Epizyme, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Epizyme, Inc. (NASDAQ:EPZM) Analysts Just Trimmed Their Revenue Forecasts By 41%
Feb 25Is Epizyme (NASDAQ:EPZM) Using Too Much Debt?
Jan 16Epizyme says Boehringer terminates collaboration agreement
Dec 24Would Shareholders Who Purchased Epizyme's (NASDAQ:EPZM) Stock Year Be Happy With The Share price Today?
Dec 12Epizyme Q3 2020 Earnings Preview
Nov 05Analisi delle retribuzioni degli amministratori delegati
Data | Compenso totale | Stipendio | Guadagni aziendali |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$208m |
Mar 31 2022 | n/a | n/a | -US$236m |
Dec 31 2021 | US$3m | US$299k | -US$251m |
Sep 30 2021 | n/a | n/a | -US$267m |
Jun 30 2021 | n/a | n/a | -US$257m |
Mar 31 2021 | n/a | n/a | -US$251m |
Dec 31 2020 | US$196k | n/a | -US$232m |
Sep 30 2020 | n/a | n/a | -US$222m |
Jun 30 2020 | n/a | n/a | -US$202m |
Mar 31 2020 | n/a | n/a | -US$192m |
Dec 31 2019 | US$309k | n/a | -US$173m |
Compensazione vs Mercato: La retribuzione totale di Grant ($USD 3.01M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 1.46M ).
Compensazione vs guadagni: La retribuzione di Grant è aumentata nonostante l'azienda non sia redditizia.
AMMINISTRATORE DELEGATO
Grant Bogle (64 yo)
less than a year
Mandato
US$3,011,807
Compensazione
Mr. Grant C. Bogle has been Chief Executive Officer, President and Director at Epizyme, Inc. since August 9, 2021 and serves as Principal Financial Officer since November 1, 2021 and served as its Independ...
Gruppo dirigente
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
President | less than a year | US$3.01m | Nessun dato | |
Chief Scientific Officer | 2.3yrs | US$2.86m | 0.0080% $ 19.9k | |
Co-Founder & Chairman of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Scientific Co-Founder & Member of The Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Chief Operating Officer | less than a year | Nessun dato | Nessun dato | |
Senior VP | 4.1yrs | Nessun dato | 0.0058% $ 14.3k | |
Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
Senior VP | no data | Nessun dato | Nessun dato | |
Chief Business Officer | 3.6yrs | Nessun dato | Nessun dato | |
Chief Regulatory Officer | 2.8yrs | Nessun dato | Nessun dato | |
Senior VP & Head of Commercial | less than a year | Nessun dato | Nessun dato | |
Laboratory Manager of Research & Development | no data | Nessun dato | Nessun dato |
2.3yrs
Durata media
56.5yo
Età media
Gestione esperta: Il team dirigenziale di EPZM è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
Nome | Posizione | Mandato | Compensazione | Proprietà |
---|---|---|---|---|
President | 2.9yrs | US$3.01m | Nessun dato | |
Co-Founder & Chairman of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Scientific Co-Founder & Member of The Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Chairman | 12.7yrs | US$370.00k | 0.19% $ 474.0k | |
Independent Director | 12.9yrs | US$350.00k | 0.0030% $ 7.4k | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Independent Director | 7.7yrs | US$330.94k | 0% $ 0 | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
Member of the Scientific Advisory Board | no data | Nessun dato | Nessun dato |
10.2yrs
Durata media
68yo
Età media
Consiglio di amministrazione esperto: Il consiglio di amministrazione di EPZM è composto da personale esperto e esperto (durata media dell'incarico 10.2 anni).